Anthony Vendetti
Stock Analyst at Maxim Group
(4.46)
# 278
Out of 4,884 analysts
80
Total ratings
30.56%
Success rate
58.58%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LSF Laird Superfood | Initiates: Buy | $12 | $6.35 | +88.98% | 1 | Jun 30, 2025 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $6 → $3 | $0.66 | +351.81% | 4 | May 21, 2025 | |
| NUTX Nutex Health | Maintains: Buy | $100 → $225 | $118.37 | +90.08% | 5 | May 20, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $14 → $10 | $4.66 | +114.59% | 6 | May 19, 2025 | |
| HAIN The Hain Celestial Group | Maintains: Buy | $10 → $5 | $1.66 | +201.20% | 8 | May 8, 2025 | |
| AMIX Autonomix Medical | Initiates: Buy | $5 | $1.42 | +252.11% | 1 | Apr 29, 2025 | |
| BIAF bioAffinity Technologies | Downgrades: Hold | n/a | $0.27 | - | 2 | Apr 1, 2025 | |
| NXL Nexalin Technology | Upgrades: Buy | $5 | $0.96 | +420.78% | 3 | Mar 24, 2025 | |
| SSKN STRATA Skin Sciences | Initiates: Buy | $6 | $2.33 | +157.51% | 1 | Feb 27, 2025 | |
| BHST BioHarvest Sciences | Initiates: Buy | $12 | $6.90 | +73.91% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.45 | - | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $8 | $0.99 | +711.77% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.40 | - | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $50 | $46.56 | +7.39% | 7 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.37 | - | 2 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $6.05 | +892.56% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.99 | +11.23% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $0.82 | +507.68% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.86 | +2,690.70% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.69 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $2.03 | -1.48% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $0.55 | +22,463.18% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.31 | +2,135.71% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $28.19 | -11.32% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.57 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $3,500 | $2.60 | +134,515.38% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $3.02 | +65.56% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.24 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.06 | +184.36% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $15.30 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $120,000 | $4.63 | +2,591,692.66% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $46.91 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.81 | +89,108.28% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.32 | -51.55% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.61 | - | 1 | May 31, 2016 |
Laird Superfood
Jun 30, 2025
Initiates: Buy
Price Target: $12
Current: $6.35
Upside: +88.98%
Dermata Therapeutics
May 21, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.66
Upside: +351.81%
Nutex Health
May 20, 2025
Maintains: Buy
Price Target: $100 → $225
Current: $118.37
Upside: +90.08%
Sensus Healthcare
May 19, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $4.66
Upside: +114.59%
The Hain Celestial Group
May 8, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.66
Upside: +201.20%
Autonomix Medical
Apr 29, 2025
Initiates: Buy
Price Target: $5
Current: $1.42
Upside: +252.11%
bioAffinity Technologies
Apr 1, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.27
Upside: -
Nexalin Technology
Mar 24, 2025
Upgrades: Buy
Price Target: $5
Current: $0.96
Upside: +420.78%
STRATA Skin Sciences
Feb 27, 2025
Initiates: Buy
Price Target: $6
Current: $2.33
Upside: +157.51%
BioHarvest Sciences
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $6.90
Upside: +73.91%
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $7.45
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $0.99
Upside: +711.77%
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $9.40
Upside: -
Sep 5, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $46.56
Upside: +7.39%
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.37
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $60
Current: $6.05
Upside: +892.56%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $8.99
Upside: +11.23%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $0.82
Upside: +507.68%
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $0.86
Upside: +2,690.70%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $11.69
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $2.03
Upside: -1.48%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $0.55
Upside: +22,463.18%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.31
Upside: +2,135.71%
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $28.19
Upside: -11.32%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.57
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $6,000 → $3,500
Current: $2.60
Upside: +134,515.38%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $3.02
Upside: +65.56%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.24
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $1.06
Upside: +184.36%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $15.30
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $120,000
Current: $4.63
Upside: +2,591,692.66%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $46.91
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.81
Upside: +89,108.28%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.32
Upside: -51.55%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $8.61
Upside: -